OVA Conjugated Major Basic Protein (MBP)
PRG2; BMPG; Proteoglycan 2; Bone Marrow,Natural Killer Cell Activator; Eosinophil Granule Major Basic Protein; Proteoglycan 2,Bone Marrow; Pregnancy-associated major basic
- Product No.CPB650Hu21
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- SourceProtein Conjugation
- Original Molecular Massn/a
- Buffer FormulationPBS, pH7.4.
- Traits Freeze-dried powder
- Purity> 90%
- Isoelectric Pointn/a
-
Applications
Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein. - DownloadInstruction Manual
- UOM 10µg50µg 200µg 1mg 5mg
- FOB
US$ 136
For more details, please contact local distributors! US$ 341 US$ 682 US$ 2046 US$ 5115
FORMULA
USAGE
Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Evid Based Complement Alternat Med | Inhibitory Action of Quercetin on Eosinophil Activation In Vitro PubMed: PMC3690238 |
Clinical and Molecular Allergy | Markers of atopic dermatitis, allergic rhinitis and bronchial asthma in pediatric patients: correlation with filaggrin, eosinophil major basic protein and … |